Cleared Traditional

K220040 - CEREPAK Uniform, Uniform XL, Uniform 3D, Heliform Soft, Heliform XtraSoft, Heliform XL, Heliform XtraSoft XL, Freeform, Freeform Mini, and Freeform XtraSoft Detachable Coil Systems (FDA 510(k) Clearance)

Jul 2022
Decision
190d
Days
Class 2
Risk

K220040 is an FDA 510(k) clearance for the CEREPAK Uniform, Uniform XL, Uniform 3D, Heliform Soft, Heliform XtraSoft, Heliform XL, Heliform XtraSoft XL, Freeform, Freeform Mini, and Freeform XtraSoft Detachable Coil Systems. This device is classified as a Device, Neurovascular Embolization (Class II - Special Controls, product code HCG).

Submitted by Medos International SARL (Le Locle, CH). The FDA issued a Cleared decision on July 14, 2022, 190 days after receiving the submission on January 5, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5950.

Submission Details

510(k) Number K220040 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 05, 2022
Decision Date July 14, 2022
Days to Decision 190 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code HCG — Device, Neurovascular Embolization
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5950

Similar Devices — HCG Device, Neurovascular Embolization

All 7
Target Detachable Coil
K252694 · Stryker Neurovascular · Dec 2025
InZone IST Detachment System
K251832 · Stryker Neurovascular · Oct 2025
Penumbra LP Coil System
K230284 · Penumbra, Inc. · Oct 2023
Target Tetra Detachable Coils
K222533 · Stryker Neurovascular · Dec 2022
InZone Detachment System
K212455 · Stryker Neurovascular · Nov 2021
Axium Detachable Coil
K203432 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Jul 2021